Advocacy intelligence hub — real-time data for patient organizations
University Hospital, Angers — NA
GlaxoSmithKline — PHASE2
Kedrion S.p.A. — PHASE3
Sinocelltech Ltd. — PHASE3
Peking University People's Hospital — PHASE2
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. — PHASE1, PHASE2
Fondazione IRCCS Policlinico San Matteo di Pavia
Fondazione IRCCS Policlinico San Matteo di Pavia
Gracell Biotechnologies (Shanghai) Co., Ltd. — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Travel grants
Travel Grants12
Amyloidosis Disease Fund
PAN Foundation
Amyloidosis Financial Assistance Program - The Assistance Fund
The Assistance Fund
Amyloidosis Foundation Patient Assistance Resources
Amyloidosis Foundation
Amyloidosis medication copay grant - PAN Foundation
PAN Foundation
PAN Foundation Amyloidosis copay grant
PAN Foundation
PAN Foundation Amyloidosis Copay Grant
PAN Foundation
PAN Foundation Amyloidosis Disease Fund
PAN Foundation
PAN Foundation Amyloidosis Patient Assistance Grant
PAN Foundation
The Assistance Fund - Amyloidosis Financial Assistance Program
The Assistance Fund
The Assistance Fund (TAF) Amyloidosis Financial Assistance Program
WAINUA Savings Program
WAINUA Way Patient Support Program
Heather Landau, MD, M.D
Memorial Sloan Kettering Cancer Center
📍 NEW YORK, NY
Raymond Comenzo, MD, MD
Tufts Medical Center
📍 BOSTON, MA
Jin Lu
Peking University People's Hospital
Debra Barton, RN, PhD, AOCN, FAAN
University of Michigan
Philip L. McCarthy, MD
Roswell Park Cancer Institute
John A. Glaspy, MD, MPH, MD
Jonsson Comprehensive Cancer Center
📍 LOS ANGELES, CA